 is
faced with combined proximal obstruction and distal
valvular reﬂux. Percutaneous iliac and caval vein stenting
has been proved safe, with low morbidity, high patency,
and satisfactory efﬁcacy. Current results demonstrate a cumulative patency rate of 90% with ulcer healing rates of
60% to 80%, depending on the cohort being treated
(Table XIII).173,413-418